CHL1

Chr 3

cell adhesion molecule L1 like

Also known as: CALL, L1CAM2

This gene encodes a neural cell adhesion molecule that facilitates cell recognition and signal transduction in the nervous system. Mutations cause an autosomal recessive developmental disorder characterized by intellectual disability, seizures, and congenital heart defects, with some patients also showing cohesinopathy-like features including growth retardation and limb malformations. The gene is highly constrained against loss-of-function variants, indicating that both copies are essential for normal neurodevelopment.

Summary from RefSeq, UniProt
Research Assistant →

Primary Disease Associations & Inheritance

UniProtWarsaw breakage syndrome
0
Active trials
21
Pubs (1 yr)
26
P/LP submissions
0%
P/LP missense
0.64
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryCHL1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
26 unique Pathogenic / Likely Pathogenic· 275 VUS of 400 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.64LOEUF
pLI 0.000
Z-score 3.83
OE 0.47 (0.350.64)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
-1.92Z-score
OE missense 1.21 (1.141.29)
785 obs / 647.3 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.47 (0.350.64)
00.351.4
Missense OE1.21 (1.141.29)
00.61.4
Synonymous OE1.27
01.21.6
LoF obs/exp: 29 / 61.4Missense obs/exp: 785 / 647.3Syn Z: -3.21
DN
0.75top 25%
GOF
0.7028th %ile
LOF
0.3068th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

400 submitted variants in ClinVar

Classification Summary

Pathogenic22
Likely Pathogenic4
VUS275
Likely Benign46
Benign19
Conflicting6
22
Pathogenic
4
Likely Pathogenic
275
VUS
46
Likely Benign
19
Benign
6
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
22
0
22
Likely Pathogenic
0
0
4
0
4
VUS
0
213
62
0
275
Likely Benign
0
20
5
21
46
Benign
0
6
6
7
19
Conflicting
6
Total02399928372

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CHL1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →